Crisafulli S, Sultana J, Fontana A et al (2020) Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis 15:141. https://doi.org/10.1186/s13023-020-01430-8

Article  PubMed  PubMed Central  Google Scholar 

Eagle M, Baudouin SV, Chandler C et al (2002) Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 12:926–929. https://doi.org/10.1016/S0960-8966(02)00140-2

Article  PubMed  Google Scholar 

Bach JR, Martinez D (2011) Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival. Respir Care 56:744–750. https://doi.org/10.4187/respcare.00831

Article  PubMed  Google Scholar 

Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17:347–361. https://doi.org/10.1016/S1474-4422(18)30025-5

Article  PubMed  PubMed Central  Google Scholar 

Silva MC, Meira ZMA, Gurgel Giannetti J et al (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49:1874–1879. https://doi.org/10.1016/j.jacc.2006.10.078

Article  PubMed  Google Scholar 

Hor KN, Taylor MD, Al-Khalidi HR et al (2013) Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. J Cardiovasc Magn Reson 15:107. https://doi.org/10.1186/1532-429X-15-107

Article  PubMed  PubMed Central  Google Scholar 

Menon SC, Etheridge SP, Liesemer KN et al (2014) Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy. Pediatr Cardiol 35:1279–1285. https://doi.org/10.1007/s00246-014-0929-z

Article  PubMed  Google Scholar 

Soslow JH, Hall M, Burnette WB et al (2019) Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity. Cardiol Young 29:290–296. https://doi.org/10.1017/S1047951118002226

Article  PubMed  PubMed Central  Google Scholar 

Wittlieb-Weber CA, Knecht KR, Villa CR et al (2020) Risk factors for cardiac and non-cardiac causes of death in males with Duchenne muscular dystrophy. Pediatr Cardiol 41:764–771. https://doi.org/10.1007/s00246-020-02309-y

Article  PubMed  PubMed Central  Google Scholar 

Florian A, Ludwig A, Engelen M et al (2014) Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients. J Cardiovasc Magn Reson 16:81. https://doi.org/10.1186/s12968-014-0081-1

Article  PubMed  PubMed Central  Google Scholar 

Wang M, Birnkrant DJ, Super DM et al (2018) Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies. Open Heart 5:e000783. https://doi.org/10.1136/openhrt-2018-000783

Article  PubMed  PubMed Central  Google Scholar 

Soslow JH, Xu M, Slaughter JC et al (2019) The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in Duchenne muscular dystrophy cardiomyopathy. J Card Fail 25:259–267. https://doi.org/10.1016/j.cardfail.2019.02.006

Article  PubMed  PubMed Central  Google Scholar 

Raucci FJ, Xu M, George-Durrett K et al (2021) Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy. J Cardiovasc Magn Reson 23:48. https://doi.org/10.1186/s12968-021-00736-1

Article  PubMed  PubMed Central  Google Scholar 

James KA, Gralla J, Ridall LA et al (2020) Left ventricular dysfunction in Duchenne muscular dystrophy. Cardiol Young 30:171–176. https://doi.org/10.1017/S1047951119002610

Article  PubMed  PubMed Central  Google Scholar 

Soslow JH, Xu M, Slaughter JC et al (2016) Evaluation of echocardiographic measures of left ventricular function in patients with Duchenne muscular dystrophy: assessment of reproducibility and comparison to cardiac magnetic resonance imaging. J Am Soc Echocardiogr 29:983–991. https://doi.org/10.1016/j.echo.2016.07.001

Article  PubMed  PubMed Central  Google Scholar 

Harris PA, Taylor R, Thielke R et al (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381. https://doi.org/10.1016/j.jbi.2008.08.010

Article  PubMed  Google Scholar 

Harris PA, Taylor R, Minor BL et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208. https://doi.org/10.1016/j.jbi.2019.103208

Article  PubMed  PubMed Central  Google Scholar 

Corrado G, Lissoni A, Beretta S et al (2002) Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89:838–841. https://doi.org/10.1016/S0002-9149(02)02195-1

Article  PubMed  Google Scholar 

Schram G, Fournier A, Leduc H et al (2013) All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. J Am Coll Cardiol 61:948–954. https://doi.org/10.1016/j.jacc.2012.12.008

Article  PubMed  Google Scholar 

Brunklaus A, Parish E, Muntoni F et al (2015) The value of cardiac MRI versus echocardiography in the pre-operative assessment of patients with Duchenne muscular dystrophy. Eur J Paediatr Neurol 19:395–401. https://doi.org/10.1016/j.ejpn.2015.03.008

Article  CAS  PubMed  Google Scholar 

Jefferies JL, Eidem BW, Belmont JW et al (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799–2804. https://doi.org/10.1161/CIRCULATIONAHA.104.528281

Article  PubMed  Google Scholar 

Puchalski MD, Williams RV, Askovich B et al (2009) Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy? Int J Cardiovasc Imaging 25:57–63. https://doi.org/10.1007/s10554-008-9352-y

Article  PubMed  Google Scholar 

Tandon A, Villa CR, Hor KN et al (2015) Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in Duchenne muscular dystrophy. J Am Heart Assoc. https://doi.org/10.1161/JAHA.114.001338

Article  PubMed  PubMed Central  Google Scholar 

Bourke JP, Watson G, Spinty S et al (2021) Preventing cardiomyopathy in DMD: a randomized placebo-controlled drug trial. Neurol Clin Pract 11:e661–e668. https://doi.org/10.1212/CPJ.0000000000001023

Article  PubMed  PubMed Central  Google Scholar